StockNews.AI
HAE
StockNews.AI
12 days

Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website

1. Haemonetics announces Q1 FY2026 financial results will be shared on August 7, 2025. 2. Conference call scheduled to discuss earnings, accessible via web and teleconference. 3. Company emphasizes commitment to improving healthcare efficiency and outcomes.

5m saved
Insight
Article

FAQ

Why Neutral?

The earnings call could reveal positive or negative results, impacting stock performance. Historically, similar earnings announcements have led to volatility but no significant pattern of consistent gains or losses.

How important is it?

The upcoming earnings release is significant for investors assessing HAE's financial health, indicating a moderate impact risk. Investor sentiment will hinge on the results and future guidance provided during the call.

Why Short Term?

The earnings announcement is imminent and will have immediate effects on stock sentiment, similar to past quarterly results-driven movements.

Related Companies

ABTBAXTERCSL
Financial release accessible online, /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its first quarter fiscal year 2026, which ended June 28, 2025, are available on its Investor Relations website.The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on August 7, 2025. The conference call and webcast can be accessed with the following information: Teleconference link:https://register-conf.media-server.com/register/BIb1de2bd7b8ba4267b7bc38da4e4008c7 Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start. A live webcast of the call can be accessed on Haemonetics' investor relations website or via the following link: https://edge.media-server.com/mmc/p/wv7zkgdh In addition, the Company has posted to its Investor Relations website the earnings release that will be referenced on its conference call and webcast, a link to which is available below.Direct link to 1Q FY26 Earnings Release:https://haemonetics.gcs-web.com/static-files/078498e0-b75c-4cd4-94fb-93730b3b1c70A replay of the conference call and webcast will be available for one year beginning on August 7, 2025, at 11:00 a.m. ET using the conference call webcast link provided in this press release.ABOUT HAEMONETICSHaemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com. Investor Contacts: Olga Guyette, Vice President-Investor Relations & Treasury  David Trenk, Manager-Investor Relations (781) 356-9763 (203) 733-4987 [email protected] [email protected] Media Contact: Josh Gitelson, Sr. Director-Global Communications (781) 356-9776 [email protected] SOURCE Haemonetics Corporation WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News